Clinical Trial Update: TNF-Inhibitor as Immune Checkpoint Inhibitor for Advanced MELanoma [Phase 1]

View source ↗

Summary

Phase 1 trial completed evaluating a tumor necrosis factor (TNF) inhibitor as an immune checkpoint therapy for advanced melanoma. Sponsor: Institut Claudius Reg…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Snippet

Sponsor: Institut Claudius Regaud | Conditions: Melanoma | Phase 1 | Status: COMPLETED